ArticleWorld journal of microbiology & biotechnology2025
Comparative and functional analyses of Bacillus paralicheniformis strains BAC30 and BAC220 by WGS uncover species homogeneity and biotechnological potential.
Article in World journal of microbiology & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Bacillus genus includes plant growth-promoting rhizobacteria (PGPR), and the discovery of new strains within this group is of great biotechnological interest due to their ability to produce antimicrobial compounds (AMCs), vitamins, enzymes, and heterologous proteins. Among these, Bacillus paralicheniformis is a recently described species whose phylogeny remains poorly resolved, highlighting the need for further investigation. This study aimed to identify and characterize the isolates BAC30 and BAC220 using whole-genome sequencing (WGS). Both were confirmed as B. paralicheniformis and included in phylogenomic and comparative analyses with 28 other strains to assess the species' genetic structure and inter-strain similarity. Functional annotation of BAC30 and BAC220 was also performed, focusing on biotechnological potential. Comparative analysis revealed high genomic similarity among strains, including the two isolates. Pangenome analysis showed a low proportion of core genes relative to accessory genes (shell and cloud), and the rarefaction curve suggested an open pangenome, indicating the species' ubiquity and co-evolution with other organisms. Functional analysis identified genes of defense mechanisms related to beta-lactam resistance. Regarding secondary metabolite production, genes involved in the biosynthesis of vitamins (e.g., riboflavin) and AMCs (e.g., bacitracin) were detected. Although further in vitro and in vivo assays are needed to confirm gene expression, the findings support the biotechnological relevance of these isolates as potential biocontrol agents and/or producers of industrially valuable compounds.
Indexed as
Identifiers
41474534What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.